American Journal of Bioethics 13 (9):3-14 (2013)

Authors
Abstract
Clinical research under the usual regulatory constraints may be difficult or even impossible in a public health emergency. Regulators must seek to strike a good balance in granting as wide therapeutic access to new drugs as possible at the same time as gathering sound evidence of safety and effectiveness. To inform current policy, I reexamine the philosophical rationale for restricting new medicines to clinical trials, at any stage and for any population of patients (which resides in the precautionary principle), to show that its objective to protect public health, now or in the future, could soon be defeated in a pandemic. Providing wider therapeutic access and coordinating observations and natural experiments, including service delivery by cluster (wedged cluster trials), may provide such a balance. However, there are important questions of fairness to resolve before any such research can proceed
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1080/15265161.2013.813597
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 71,172
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

The Economics of Justice.Richard A. Posner (ed.) - 1981 - Harvard University Press.
The Economics of Justice.Richard A. Posner - 1983 - Law and Philosophy 2 (1):129-136.
Evidence and Ethics in Medicine.John Worrall - 2008 - Perspectives in Biology and Medicine 51 (3):418-431.

View all 16 references / Add more references

Citations of this work BETA

View all 16 citations / Add more citations

Similar books and articles

The Clinical Ethicist at the Bedside.John Puma & David L. Schiedermayer - 1991 - Theoretical Medicine and Bioethics 12 (2).
A Strategy of Clinical Tolerance for the Prevention of Hiv and Aids in China.Yanguang Wang - 2000 - Journal of Medicine and Philosophy 25 (1):48 – 61.
Health Science, Natural Science, and Clinical Knowledge.R. John Bench - 1989 - Journal of Medicine and Philosophy 14 (2):147-164.

Analytics

Added to PP index
2013-10-26

Total views
8 ( #1,009,939 of 2,517,879 )

Recent downloads (6 months)
1 ( #409,482 of 2,517,879 )

How can I increase my downloads?

Downloads

My notes